So much news to get through over the last 48 hours, but I wonder if there has there been enough focus on the combination study with Keytruda here?
Merck’s willingness to combine with Vaxinia at such an early stage is bloody exciting. Understandably it is early doors, and the science needs to play out, but US14B in annual sales in 2020 sure is something…
So much news to get through over the last 48 hours, but I wonder...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |